H1N1 Vaccine Trials in HIV-Infected People
October 13, 2009
Clinical trials of the 2009 H1N1 influenza vaccine have begun among HIV-positive pregnant women to determine if the product safely elicits a protective immune response, the National Institutes of Health announced Friday. Another trial of the same test begins this week among HIV-infected children and youth, said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which is part of NIH.
United Press International
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.